Globus Medical (GMED)Director sold ~$585K

~$585K

Approx. value · 10K sh @ $58.46

25K

Holds after · shares reported

Traded

Sep 15, 2025

Filed

Sep 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 17, 2025CongressDisclosed purchase of GMED — reported range $1,001 - $15,000
2. Jun 24, 2025CongressDisclosed partial sale of GMED — reported range $1,001 - $15,000
3. Jul 10, 2025CongressDisclosed sale of GMED — reported range $1,001 - $15,000
4. Sep 15, 2025 · this disclosureInsiderDirector sold ~$585K of GMED shares in the open market

What came next

1. Oct 16, 2025Federal contract · $25K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $25K obligated to date
2. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
3. Nov 7, 2025InsiderDirector sold ~$648K of GMED shares in the open market
4. Nov 10, 2025InsiderDirector sold ~$170K of GMED shares in the open market
5. Nov 11, 2025InsiderDirector sold ~$2.11M of GMED shares in the open market
6. Nov 12, 2025InsiderDirector sold ~$2.15M of GMED shares in the open market
7. Nov 25, 2025InsiderOfficer sold ~$675K of GMED shares in the open market
8. Dec 12, 2025InsiderDirector sold ~$355K of GMED shares in the open market
9. Jan 7, 2026Company filing · Form 8-K · ResultsReported its results
10. Jan 8, 2026Insider · 2 peopleInsiders: 2 sales (~$566K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Globus Medical

For Globus Medical, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 12 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GMED page.

Other recent filings by Ann D Rhoads, Director

• SEC Form 4 at Globus Medical (GMED)Nov 10, 2025
• SEC Form 4 at Globus Medical (GMED)Nov 10, 2025
• SEC Form 4 at Globus Medical (GMED)Mar 4, 2025

The full history of Ann D Rhoads, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Globus Medical

• SEC Form 4Sep 16, 2026
• House Clerk periodic transaction reportSep 10, 2026
• USAspending.gov award recordAug 20, 2026
• SEC Form 4Aug 19, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its GMED page.